Jurickson Profar, a once-promising star in Major League Baseball, is facing a significant setback as he receives a 162-game suspension for violating the league's performance-enhancing drug (PED) policy. This news comes as a shock to many, especially considering Profar's recent performance and the Braves' decision to sign him to a substantial three-year contract. But here's where it gets controversial... Profar's suspension raises questions about the effectiveness of the league's drug testing and the potential risks associated with performance-enhancing substances. While some may argue that the suspension is justified, others might wonder if the Braves should have been more cautious in their decision to sign him. And this is the part most people miss... Profar's suspension also has implications for the Braves' roster and their plans for the upcoming season. With a pair of notable injuries in the rotation and the need for additional help, the Braves now have an influx of cash that could be used to acquire a starting pitcher or a veteran right-handed bat. But will they use these funds immediately or save them for in-season additions? The Braves' decision-making process in the wake of Profar's suspension will be a topic of much discussion and debate among baseball fans and experts alike. So, what do you think? Do you agree with the suspension, or do you think the Braves should have handled the situation differently? Share your thoughts in the comments below!
